PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.47
Similar ESG score to EYEN's 61.51. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
53.73
Environmental score 90-95% of EYEN's 59.00. Bill Ackman would demand clear environmental improvement catalysts.
61.12
Social score 90-95% of EYEN's 65.64. Bill Ackman would demand clear social improvement catalysts.
60.56
Similar governance score to EYEN's 59.88. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.